Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.
1 other identifier
interventional
550
1 country
1
Brief Summary
Colorectal cancer is one of the most frequent and it prognosis is still serious. In France, diagnosis and screening applicated in numerous departements, and now in a path of generalization to the all country, is based on combination of searching blood into bowel movements (Haemoccult) for the screening of population with medium risk (age between 50 to 74 years old)and colonoscopy for the screening and diagnosis of pre-cancerous lesions for the patients with a high risk.Even if the efficiency of this strategy is proved, searching blood into the bowel movement by Haemoccult is still imperfect (a lot of false negative). Colonoscopy is not an ideal tool for screening. Indeed, its acceptability is not perfect and it constitute an invasive method, with complications, with a compulsory general anesthesia, implicating a high cost. The alternative of a screening method based on a non invasive method is required.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Apr 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2007
CompletedFirst Posted
Study publicly available on registry
February 19, 2007
CompletedStudy Start
First participant enrolled
April 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedJuly 23, 2009
July 1, 2009
2.3 years
February 16, 2007
July 21, 2009
Conditions
Keywords
Interventions
4l of PEG during 2 days
2x 10mg Motilium, 2 Fleet Phospho soda (one is facultative) and 1 dulcolax (facultative)
1l of PEG the morning just before colonoscopy
Eligibility Criteria
You may qualify if:
- age between 18 and 80 years
- patient able to give his informed consent
- No colorectal, intestinal inflammatory, ischemic or evolving infectious pathologies
- No signs of stenosis of small intestine or colon
- No contraindication to anesthesia
- No participation to an other clinical study
- Patient with and indication to colonoscopy for searching of a colorectal neoplasia during a screening program OR
- Patient for who a endoscopic following is required because of familial cases or personal cases of polyps or colorectal cancer
You may not qualify if:
- Presence of symptoms evocating an occlusive pathology
- Recent complicated colic diverticulosis
- No informed consent
- pregnancy or no use of efficient contraception treatment
- Patient with a pace-maker or others internal medical electronic device
- Evolved nephric or cardiac insufficiencies
- Hypersensibility to Fleet Phospho Soda (or one of the excipient), bisacodyl (or one of the excipient), motilium (or one of the excipient)
- Presence of a prolactinoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nantes
Nantes, 44093, France
Related Publications (1)
Sacher-Huvelin S, Coron E, Gaudric M, Planche L, Benamouzig R, Maunoury V, Filoche B, Frederic M, Saurin JC, Subtil C, Lecleire S, Cellier C, Coumaros D, Heresbach D, Galmiche JP. Colon capsule endoscopy vs. colonoscopy in patients at average or increased risk of colorectal cancer. Aliment Pharmacol Ther. 2010 Nov;32(9):1145-53. doi: 10.1111/j.1365-2036.2010.04458.x. Epub 2010 Sep 16.
PMID: 21039676DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jean Paul Galmiche, MD
Nantes University Hospital
- PRINCIPAL INVESTIGATOR
Stanislas Chaussade, MD
Hôpital Cochin
- PRINCIPAL INVESTIGATOR
Marie-Georges Lapalus, MD
Hospices Civils de Lyon
- PRINCIPAL INVESTIGATOR
Christophe Cellier, MD
CHU Pompidou
- PRINCIPAL INVESTIGATOR
Denis Heresbach, MD
Rennes University Hospital
- PRINCIPAL INVESTIGATOR
Bernard Filoche, MD
CH de Saint Philibert
- PRINCIPAL INVESTIGATOR
Vincent Maunoury, MD
CHU de Lille
- PRINCIPAL INVESTIGATOR
Gerard Gay, MD
Central Hospital, Nancy, France
- PRINCIPAL INVESTIGATOR
Thierry Barrioz, MD
Poitiers University Hospital
- PRINCIPAL INVESTIGATOR
Emmanuel Ben Soussan, MD
University Hospital, Rouen
- PRINCIPAL INVESTIGATOR
Dimitri Coumaros, MD
CHU de Strasbourg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 16, 2007
First Posted
February 19, 2007
Study Start
April 1, 2007
Primary Completion
July 1, 2009
Study Completion
July 1, 2009
Last Updated
July 23, 2009
Record last verified: 2009-07